npub1a73wyr3s8ffagwsnlfd548d0nsaqcwdnn6550akehaxglw3kzc8qce7y6q (npub1a73…7y6q) I mean if you look at the company pipeline, they have developed and sold several. Sold several of the companies under Rovian to a Japanese Pharma company -
Buying patents or in-licensing frequently happens in the space, not a big deal. Identifying a novel (new) molecule to treat a disease is challenging and costly - so why not buy the initial work up front if you think you can develop it to a viable product.